Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis

Abstract

Thyroxine therapy alone does not represent a significant risk factor for loss of bone mineral density but there is a risk of bone loss in post-menopausal (but not premenopausal) females with a previous history of thyrotoxicosis treated with radioiodine.